Davis D A, Pellowski D M, Davis D A, Donahoo W T
Department of Dermatology, University of Arkansas for Medical Sciences, Arkansas, USA.
Int J Obes (Lond). 2006 Aug;30(8):1217-22. doi: 10.1038/sj.ijo.0803120. Epub 2006 Mar 7.
The most common surgical procedure for obesity is liposuction, the majority of which are small-volume procedures. The effect of large-volume liposuction on cardiovascular risk and insulin sensitivity has been variable. This study was performed to evaluate the effect of the more common, smaller-volume liposuction on insulin sensitivity, inflammatory mediators, and cardiovascular risk factors.
In all, 15 overweight or obese premenopausal women underwent metabolic evaluation prior to, 1 day following and 1 month following suction lipectomy of the abdomen. Metabolic evaluation included assessment of free fatty acids, glucose, insulin, insulin sensitivity by frequently sampled i.v. glucose tolerance test, and adipokines (IL-6, angiotensin II, leptin, PAI-1, adiponectin, and TNF-alpha).
Free fatty acids did not change acutely although there was an almost 30% decrease in free fatty acids at 1 month. Fasting insulin levels decreased at one month from 8.3 +/- 1.1 to 5.6 +/- 1.3 microU/ml (P = 0.006). Insulin sensitivity by i.v. glucose tolerance test did not change at 1 month (4.0 +/- 0.8 to 5.0 +/- 0.7, P = 0.12) although with subgroup analysis insulin sensitivity improved in obese but not overweight participants. Several adipokines worsened acutely (IL-6 increased 15 fold and angiotensin II increased 67%), but there was no change in PAI-1, and other adipokines (adiponectin, leptin, and TNF-alpha) decreased. At the 1-month follow-up, all adipokines were similar to baseline.
This study provides little evidence supporting increased or decreased cardiovascular risk although there is evidence supporting improved insulin sensitivity at one month, especially in obese women.
肥胖最常见的外科手术是抽脂术,其中大多数是小容量手术。大容量抽脂术对心血管风险和胰岛素敏感性的影响一直存在差异。本研究旨在评估更常见的小容量抽脂术对胰岛素敏感性、炎症介质和心血管危险因素的影响。
共有15名超重或肥胖的绝经前女性在腹部抽脂术前、术后1天和术后1个月接受了代谢评估。代谢评估包括对游离脂肪酸、葡萄糖、胰岛素、通过频繁取样静脉葡萄糖耐量试验评估的胰岛素敏感性以及脂肪因子(白细胞介素-6、血管紧张素II、瘦素、纤溶酶原激活物抑制剂-1、脂联素和肿瘤坏死因子-α)的评估。
游离脂肪酸虽在术后1个月时有近30%的下降,但未出现急性变化。空腹胰岛素水平在1个月时从8.3±1.1微单位/毫升降至5.6±1.3微单位/毫升(P = 0.006)。静脉葡萄糖耐量试验评估的胰岛素敏感性在1个月时未发生变化(从4.0±0.8变为5.0±0.7,P = 0.12),不过亚组分析显示肥胖参与者的胰岛素敏感性有所改善,而超重参与者则未改善。几种脂肪因子出现急性恶化(白细胞介素-6增加了15倍,血管紧张素II增加了67%),但纤溶酶原激活物抑制剂-1未发生变化,其他脂肪因子(脂联素、瘦素和肿瘤坏死因子-α)则有所下降。在1个月的随访中,所有脂肪因子均与基线水平相似。
本研究几乎没有证据支持心血管风险增加或降低,不过有证据表明在1个月时胰岛素敏感性有所改善,尤其是在肥胖女性中。